Iron Sucrose



Indications and Reactions:

Role Indications Reactions
Primary
Anaemia 30.0%
Iron Deficiency Anaemia 30.0%
Anemia 15.0%
Iron Deficiency 10.0%
Haematochezia 5.0%
Serum Ferritin Decreased 5.0%
Serum Sickness 5.0%
Dyspnoea 7.7%
Infusion Site Discolouration 7.7%
Nausea 7.7%
Pain In Extremity 7.7%
Presyncope 7.7%
Urticaria 7.7%
Anaphylactic Reaction 3.8%
Deep Vein Thrombosis 3.8%
Hypotension 3.8%
Incorrect Drug Administration Rate 3.8%
Oedema Peripheral 3.8%
Pallor 3.8%
Paraesthesia 3.8%
Pyrexia 3.8%
Rash 3.8%
Rash Maculo-papular 3.8%
Refusal Of Treatment By Patient 3.8%
Respiratory Depression 3.8%
Somnolence 3.8%
Swollen Tongue 3.8%
Secondary
Product Used For Unknown Indication 32.1%
Gastrointestinal Haemorrhage 17.0%
Crohn's Disease 11.3%
Nephrogenic Anaemia 7.5%
Normochromic Normocytic Anaemia 7.5%
Pneumonia 7.5%
Iron Deficiency 3.8%
Peritoneal Dialysis 3.8%
Renal Transplant 3.8%
Iron Deficiency Anaemia 1.9%
Renal Failure Chronic 1.9%
Therapeutic Skin Care Topical 1.9%
Infusion Related Reaction 35.3%
Cerebral Haemorrhage 11.8%
Liver Disorder 11.8%
Platelet Count Decreased 11.8%
Adverse Drug Reaction 5.9%
Application Site Vesicles 5.9%
Pneumonia 5.9%
Toxic Epidermal Necrolysis 5.9%
Urticaria 5.9%
Concomitant
Product Used For Unknown Indication 27.5%
Drug Use For Unknown Indication 27.4%
Prophylaxis 8.7%
Crohn's Disease 5.4%
Arthritis Bacterial 5.3%
Anaemia 4.6%
Hypertension 3.2%
Diabetes Mellitus 3.0%
Nephrogenic Anaemia 1.8%
Dyspepsia 1.7%
Pain 1.6%
Anticoagulant Therapy 1.3%
Diarrhoea 1.2%
Gastrooesophageal Reflux Disease 1.2%
Peritoneal Dialysis 1.2%
Osteomyelitis 1.0%
Iron Deficiency Anaemia 0.9%
Thrombosis Prophylaxis 0.9%
Convulsion 0.9%
Hepatic Neoplasm Malignant 0.9%
Rhabdomyolysis 19.7%
Therapeutic Response Decreased 10.7%
Anti-erythropoietin Antibody Positive 9.8%
Full Blood Count Decreased 9.8%
Vomiting 5.7%
Death 4.9%
Drug Ineffective 4.1%
Haemoglobin Decreased 4.1%
Respiratory Tract Infection 4.1%
Skin Induration 3.3%
Weight Decreased 3.3%
Drug Interaction 2.5%
Hepatic Failure 2.5%
Hypokalaemia 2.5%
Nephrogenic Systemic Fibrosis 2.5%
Paraparesis 2.5%
Tracheo-oesophageal Fistula 2.5%
Ventricular Tachycardia 2.5%
Anaemia 1.6%
Cardiac Failure Acute 1.6%